8-K
filed December 12, 2022, 6:59 PM ET
ticker SER
CIK 0001708599
other
confidence high
sentiment neutral
materiality 0.55
AgeX stockholders approve doubling authorized shares to 200M and adding 4M shares to equity plan
Serina Therapeutics, Inc.
- Elected directors Bailey, Hackett, May, West with ~20.4M-20.7M votes each; 5.2M broker non-votes.
- Ratified WithumSmith+Brown as auditor for FY2022: 26.8M for, 31K against.
- Approved amendment to increase authorized common stock from 100M to 200M shares (20.8M for, 1.3M against).
- Approved 2017 Equity Incentive Plan amendment adding 4M shares, total now 8.5M shares available (20.1M for).
- Approved Juvenescence proposal to acquire >19.9% or 50%+ of AGE shares via warrants/loan conversion (20.4M for).
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Serina Therapeutics, Inc. shareholders approved Common Stock Amendment Proposal - amendment to Certificate of Incorporation to increase authorized shares from 100,000,000 to 200,000,000 at the 2022-12-07 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2022-12-07
Exact text from the filing
Common Stock Amendment Proposal The Common Stock Amendment Proposal was approved by the following vote: Shares Voted For 20,798,910 Against 1,341,037 Abstain 22,781 In addition, there were 4,736,638 broker non-votes on this matter.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Serina Therapeutics, Inc. shareholders approved Incentive Plan Amendment Proposal - amendment of 2017 Equity Incentive Plan to make additional 4,000,000 shares available at the 2022-12-07 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2022-12-07
Exact text from the filing
Incentive Plan Amendment Proposal The Incentive Plan Amendment Proposal was approved by the following vote: Shares Voted For 20,127,120 Against 1,474,349 Abstain 53,488 In addition, there were 5,244,408 broker non-votes on this matter.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Serina Therapeutics, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accountants at the 2022-12-07 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2022-12-07
Exact text from the filing
Ratification of Appointment of Independent Registered Public Accountants The appointment of WithumSmith + Brown PC as our independent registered public accountants for the fiscal year ending December 31, 2022 was ratified by the following vote: Shares Voted For 26,776,985 Against 31,458 Abstain 90,923 There were no broker non-votes on this matter.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Serina Therapeutics, Inc. shareholders approved Election of Directors at the 2022-12-07 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2022-12-07
Exact text from the filing
Election of Directors Each of the following nominees were elected as directors by the following vote: Nominee Votes For Votes Withheld Gregory Bailey 20,443,999 1,210,959 Joanne Hackett 20,457,478 1,197,480 Michael May 20,469,901 1,185,057 Michael D. West 20,685,723 969,235 In addition, there were 5,244,408 broker non-votes with respect to the election of directors.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Serina Therapeutics, Inc. shareholders approved Juvenescence Proposal - to permit Juvenescence Limited to acquire additional shares of AgeX common stock through exercise of warrants or conversion of loans at the 2022-12-07 meeting.
- Outcome
- passed
- Meeting
- 2022-12-07
Exact text from the filing
Juvenescence Proposal The Juvenescence was approved by the following vote: Shares Voted For 20,393,670 Against 1,204,612 Abstain 56,676 In addition, there were 5,244,408 broker non-votes on this matter.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.